130351-68-7

Basic information

• Product Name: Uridine, 5'-O-[(1,1-dimethylethyl)diphenylsilyl]-
• CAS NO: 130351-68-7
• Molecular Formula: C25H30N2O6Si
• Molecular Weight: 482.608
• Mol File: 130351-68-7.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: Uridine, 5'-O-[(1,1-dimethylethyl)diphenylsilyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Uridine, 5'-O-[(1,1-dimethylethyl)diphenylsilyl]-(130351-68-7)
• EPA Substance Registry System: Uridine, 5'-O-[(1,1-dimethylethyl)diphenylsilyl]-(130351-68-7)

Safety Data

• Hazardous Substances Data: 130351-68-7(Hazardous Substances Data)

Upstream product

• 58479-61-1 tert-butylchlorodiphenylsilane 
• 58-96-8 uridine 

Downstream Products

• 160905-80-6 5'-O-(tert-butyldiphenylsilyl)-2'.3'-bis-O-(9-phenylxanthen-9-yl)uridine 
• 130351-69-8 1-<5-O-(tert-butyldiphenylsilyl)-2,3-epoxy-β-D-lyxo-pentofuranosyl>uracil 
• 190723-42-3 Methanesulfonic acid (2R,3R,4R,5R)-2-(tert-butyl-diphenyl-silanyloxymethyl)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-methanesulfonyloxy-tetrahydro-furan-3-yl ester 
• 187971-24-0 2-Chloro-benzoic acid (2R,3R,4R,5R)-5-(tert-butyl-diphenyl-silanyloxymethyl)-2-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-hydroxy-tetrahydro-furan-3-yl ester 
• 132364-17-1 1-[5-O-(tert-butyldiphenylsilyl)-2,3-dideoxy-β-D-glycero-pento-2-enofuranosyl]uracil 
• 215110-26-2 5-[(S)-5-(tert-Butyl-diphenyl-silanyloxy)-4-hydroxy-pentyl]-1H-pyrimidine-2,4-dione 
• 187971-25-1 2-Chloro-benzoic acid (2R,3R,4R,5R)-5-(tert-butyl-diphenyl-silanyloxymethyl)-2-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-methylsulfanylmethoxy-tetrahydro-furan-3-yl ester 
• 187971-27-3 2-Chloro-benzoic acid (2R,3R,4R,5R)-2-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethoxymethoxy]-5-hydroxymethyl-tetrahydro-furan-3-yl ester 
• 187971-28-4 C₄₆H₄₃ClN₄O₁₄ 
• 187971-26-2 C₅₄H₇₃ClN₄O₁₃Si₃ 
• 190723-52-5 1-[(2R,5R)-5-(tert-Butyl-diphenyl-silanyloxymethyl)-4-phenylselanyl-2,5-dihydro-furan-2-yl]-1H-pyrimidine-2,4-dione 
• 190723-60-5 (1R,2S,4R,5S,6S)-2-(tert-Butyl-diphenyl-silanyloxymethyl)-6-cyano-4-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-3-oxa-bicyclo[3.1.0]hexane-6-carboxylic acid 

Relevant articles and documents

2′,3′-Cyclopropanated Nucleoside Dimers

Syntheses of three novel conformationally rigid dimers containing cyclopropyl -amide and -sulfonamide functionalities are described. Their incorporation into an oligonucleotide sequence resulted in considerable lowering of the Tm's in binding to their complementary RNA sequences.

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

Disclosed herein are compositions and pharmaceutical formulations that comprise a binding moiety conjugated to a modified polynucleic acid molecule and a polymer. Also described herein include methods for treating a cancer which utilize a composition or a pharmaceutical formulation comprising a binding moiety conjugated to a polynucleic acid molecule and a polymer.

Synthesis and cell transfection properties of cationic uracil-morpholino tetramer

Synthesis and cell transfection properties of guanidinium-functionalized uracil morpholino tetramer have been reported for the first time. Due to the basic nature of guanidinium groups they remain protonated under physiological conditions. Such cationic tetramer exhibits efficient cellular uptake properties as visualized by microscopy imaging using fluorescent dye BODIPY. 7′-End of this morpholino tetramer was functionalized with an azide group for conjugation with various types of biomolecules or drugs for cellular delivery.